Short answer · Medically reviewed summary · Last updated: 2026-05-08
Kernicterus is a preventable form of permanent brain damage caused by extremely high levels of unconjugated bilirubin in a newborn's blood, which crosses the blood-brain barrier and damages the basal ganglia and brainstem. While the primary cause is severe hyperbilirubinemia, the condition occurs when bilirubin neurotoxicity exceeds the infant's protective biological mechanisms. What triggers the development of Kernicterus? The fundamental cause of Kernicterus is the accumulation of free, unconjugated bilirubin that has not been bound to albumin.
Kernicterus is a preventable form of permanent brain damage caused by extremely high levels of unconjugated bilirubin in a newborn's blood, which crosses the blood-brain barrier and damages the basal ganglia and brainstem. While the primary cause is severe hyperbilirubinemia, the condition occurs when bilirubin neurotoxicity exceeds the infant's protective biological mechanisms.
The fundamental cause of Kernicterus is the accumulation of free, unconjugated bilirubin that has not been bound to albumin. When bilirubin levels rise rapidly—often due to hemolysis (the breakdown of red blood cells)—the liver may be unable to process it quickly enough. If the bilirubin levels overwhelm the blood-brain barrier, it deposits in specific brain regions, leading to the irreversible neurological injury characteristic of Kernicterus.
Genetic factors can significantly increase an infant's susceptibility to developing Kernicterus. While the condition is not "hereditary" in the traditional sense, certain underlying conditions make it more likely:
It is vital to distinguish between a cause and a risk factor. The cause is the toxic level of bilirubin, while risk factors are the variables that make that toxicity more likely to occur. These include prematurity, significant bruising during birth, sepsis, and delayed diagnosis of jaundice. Among the 146 members of the Kernicterus community on DiseaseMaps.org, many families report that early detection of these risk factors was the turning point in preventing severe outcomes.
While the mechanism of bilirubin neurotoxicity is well-established, researchers are still investigating why some infants develop Kernicterus at lower bilirubin levels than others. Current research is focused on identifying biomarkers that predict which infants are most vulnerable, as well as refining phototherapy and exchange transfusion protocols to further reduce the global incidence of Kernicterus.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.